,,iv #aag? ,,congress #b;d ,session ,h4 ,,res4 #acij ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,septemb] #bb1 #bjbb,mrs4 ,napolitano 7= h]self1 ,mr4 ,katko1 ,ms4 ,lee ( ,cali=nia1 ,miss ,gonzlez-,coln1 ,mr4 ,fitzpatrick1 ,ms4 ,roybal-,all>d1 ,ms4 ,matsui1 ,mr4 ,soto1 ,mr4 ,trone1 ,mr4 ,sires1 ,mr4 ,grijalva1 & ,mr4 ,crd5as7 submitt$ ! foll[+ resolution2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce1 & 9 addition to ! ,committee on ,ways & ,means1 = a p]iod to be subsequ5tly det]m9$ by ! ,speak]1 9 ea* case = consid]ation ( su* provisions z fall )9 ! jurisdiction ( ! committee conc]n$ ,,resolution ,express+ support = ! protection ( ,m$ic>e "p ,d's six protect$ classes4 ,:]eas ,m$ic>e "p ,d 0 e/abli%$ by ,congress 9 #bjjc to provide mu*-ne$$ prescription drug cov]age = s5iors & p ) disabilities2 ,:]eas dur+ implem5tation1 ! ,c5t]s = ,m$ic>e ,m$icaid ,s]vices 7,,cms7 id5tifi$ six classes & categories ( m$ic9es :]e pati5ts c\ld face s]i\s risks1 complications1 & negative heal? outcomes )\t access to ^! m$ic9es2 ,:]eas ,,cms requires "p ,d plans to cov] all or sub/antially all m$ication )9 ^! six classes1 :i* help protect pati5ts ne$+ antidepressants1 antipsy*otics1 anticonvulsants1 immunosuppressants1 antiretrovirals1 & ant9eopla/ics2 ,:]eas ^! m$ications help treat pati5ts )1 b n limit$ to1 epilepsy1 organ transplants1 canc]1 ,,hiv_/,,aids1 & m5tal heal? conditions2 ,:]eas1 9 ! pa/1 ,,cms has consid]$ *anges t impact ! accessibility ( ^! m$ic9es2 ,:]eas prior propos$ *anges w\ld h p]mitt$ c]ta9 heal? plans to limit or r$uce cov]age ( drugs 9 ! protect$ classes2 ,:]eas prior propos$ *anges h fail$ to consid] ! ne$ = ,m$ic>e b5efici>ies to h access to treatm5ts t are be/ = _! condition7s7 or ! necessity & *all5ges to det]m9e ! be/ regim5 to meet ^? ne$s2 ,:]eas if pati5ts are unable to obta9 ! m$ic9es !y ne$1 _m w exp]i5ce co/ly & avoidable complications t c\ld increase ov]all co/s to ! ,m$ic>e ,program1 r$uce _! quality ( life1 or ev5 limit life itself2 ,:]eas su* *anges w\ld directly t>get "s ( our mo/ vuln]able citiz5s2 ,:]eas prior propos$ *anges are p>ticul>ly worrisome giv5 ! unique1 (t5 complex1 m$ical ne$s ( "s ,m$ic>e b5efici>ies2 ,:]eas b5efici>ies ) s*izophr5ia :o are /abiliz$ on m$ication & !n =c$ to utilize a diff]5t m$ic9e are at risk ( a relapse2 ,:]eas ?is w\ld lead to high] m$ical co/s 9 ! =m ( pot5tially avoidable psy*iatric hospitalizations1 z well z exac]bate pati5ts' comorbid m$ical conditions2 ,:]eas individuals ) depression (t5 ne$ to try sev]al m$ic9es be=e f9d+ "o t provides symptom relief2 ,:]eas hav+ only "o or two drugs to treat ! wide-rang+ ways someone c\ld pres5t ) depression is simply inadequate1 especially among an old] population :]e depression is a significant pr$ictor ( suicide2 ,:]eas access to m$ications is ess5tial = ^? :o exp]i5ce m5tal heal? conditions1 :i* are (t5 co-occurr+ ) o!r conditions1 su* z ,p>k9son's disease2 ,:]eas = p liv+ ) ,,hiv1 new drug !rapies h sav$ millions ( lives & prolong$ millions m2 ,:]eas ! adv5t ( antiretroviral m$ications %ift$ ! prognosis = an individual diagnos$ ) ,,hiv f a ne>-c]ta9 dea? to a manageable disease1 :5 pati5ts h access to quality c>e & m$ications2 ,:]eas n all ,,hiv_/,,aids m$ications are ! same1 & ea* p]son may react diff]5tly to a p>ticul> m$ication2 ,:]eas disruptions or delays 9 access to ,,hiv treatm5t c h s]i\s consequ5ces = pati5ts & c increase ! risk ( ,,hiv transmission to o!rs2 ,:]eas = p liv+ ) ,,hiv1 drug resi/ance c occur1 & !y mu/ h ! ability to swit* to ano!r drug )\t int]ruption2 ,:]eas ,,hiv disproportionately affects m9ority populations1 &1 9 #bjbj1 #dc p]c5t ( p newly diagnos$ ) ,,hiv 7 ,black1 al?\gh ,black ,am]icans repres5t only #ab p]c5t ( ! ,unit$ ,/ates population1 & 9 #bjai1 ,hispanic p repres5t$ #bi p]c5t ( ^? newly diagnos$ ) ,,hiv b only #af p]c5t ( ! ,unit$ ,/ates population2 ,:]eas access to oncology drugs 7ant9eopla/ics7 is crucial = canc] pati5ts because drugs 9 ^! classes are n always int]*angeable2 ,:]eas oncology pati5ts may respond diff]5tly to diff]5t treatm5ts1 ne$ to access alt]native treatm5ts bas$ on *anges 9 _! condition1 or h few] or m tol]able side effects if !y use "o !rapy in/ead ( ano!r2 ,:]eas at lea/ #a1ajj1jjj ,m$ic>e b5efici>ies live ) epilepsy2 ,:]eas epilepsy m$ications1 kn[n z anticonvulsants or antiseizure m$ications1 are n int]*angeable2 ,:]eas p ) epilepsy :o _c access or are =c$ to swit* f ! mo/ effective anticonvulsant are at increas$ risk ( break?r\gh seizures & relat$ complications includ+ injury1 disability1 & dea?2 ,:]eas seizure-free individuals :o are =c$ to swit* _! m$ication h ne>ly a #ag-p]c5t rate ( seizure reoccurr5ce comp>$ to less ?an #c p]c5t among p rema9+ on ! mo/ effective m$ication2 ,:]eas elim9at+ immunosuppressants f ! li/ ( protect$ classes w\ld place p]sons :o receiv$ any transplant at risk = sev]e m$ical complications2 ,:]eas immunosuppressive m$ications are n int]*angeable2 ,:]eas if prescription drugs are fill$ )\t reg>d to consi/5cy f "o mon? to ! next1 ! recipi5t is subject to increas$ risk ( organ rejection1 along ) additional cl9ic visits1 lab co/s1 & pot5tial hospitalization2 ,:]eas ?is includes individuals :o take ^! same m$ications to manage _! autoimmune disord]s1 includ+ lupus1 psoriasis1 rheumatoid ar?ritis1 ,crohn's disease1 & multiple scl]osis2 ,:]eas "p ,d plans are already equipp$ ) tools to manage sp5d+ & enc\rage ! use ( g5]ics1 :5 possible & appropriate1 = ! six protect$ classes2 ,:]eas1 accord+ to an analysis ( ,,cms data by ! ,pew ,*>itable ,tru/s1 ! g5]ic utilization rate 9 ! six protect$ classes is z high z #ib p]c5t2 & ,:]eas pot5tial *anges to ! six protect$ classes h n[ be5 reject$ dur+ ! ,obama1 ,trump1 & ,bid5 adm9i/rations aft] receiv+ significant opposition f ,congress1 pati5t gr\ps1 provid]s1 & /akehold]s3 ,n[1 !re=e1 be x ,t ! ,h\se ( ,repres5tatives-- 7#a7 supports ! six protect$ classes policy because x e/abli%$ critical access protection = _m ( our mo/ vuln]able ,m$ic>e b5efici>ies2 7#b7 recognizes t ,m$ic>e "p ,d b5efici>ies curr5tly ne$+ antidepressants1 antipsy*otics1 anticonvulsants1 immunosuppressants1 antiretrovirals1 & ant9eopla/ics dep5d on ! protection ( ! six protect$ classes to meet _! complex m$ical ne$s & highly p]sonaliz$ treatm5ts2 & 7#c7 enc\rages ! ,c5t]s = ,m$ic>e ,m$icaid ,s]vices to cont9ue to "w ) ,congress1 pati5t gr\ps1 provid]s1 & /akehold]s to secure long-t]m protection ( ! six protect$ classes policy4